The Linde Group, Air Liquide and Air Products and Chemicals, Inc. are Dominating the Industry for "Global Medical Gas Market" During Forecast Period 2019-2026

Global medical gas market is expected to reach a healthy CAGR of 7.2% in the forecast period of 2019 to 2026.

A medical gas is the gas which is manufactured, packaged, and planned for administration to a patient in therapy, anaesthesia, or diagnosis purposes. The medical gases are mainly used in home healthcare, hospitals, biotechnology & pharmaceutical companies, emergency service providers and also in academic & research institutions. Medical Air, Carbon Dioxide, Oxygen, Nitrogen and Nitrous Oxide are the most common used medical gases in the hospital areas including recovery areas, patient rooms, operating rooms, and others.

Global Medical Gas Market By Product (Medical Gases, Medical Gas Equipment),Application (Pharmaceutical Manufacturing & Research, Diagnostic Applications, Therapeutic Applications, Others), Method Of Separation (Physical Separators, Fractional Distillation, Molecular Sieve, Semipermeable Membrane, Others), End User (Hospitals, Home Healthcare, Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Emergency Service Providers, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Click Here For Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-gases-market

THE LINDE GROUP

The company was founded in 1880, headquarter in Dublin, Republic of Ireland .The company is involved in innovating and manufacturing medical gases and medical gas mixture, including calibration gases, medicinal oxygen, inhaled nitric oxide, medical carbon dioxide, helium/oxygen mixtures, nitrogen etc., which are key components of medical gases. The main business segments of the company are Products and Category. The revenue of the company is USD 21,074.15 Million. Number of employees is 57,605. The company has global presence in EMEA, Americas, and Asia Pacific.

In January 2017, Linde Gas North America LLC, a subsidiary of Linde gas, has acquired a leading provider of respiratory equipment repair services and medical oxygen. This acquisition will help Linde Gas in strengthening their medical gas market in the U.S.

AIR LIQUIDE

The company was founded in 1902, headquarter in Paris, France. Company is involved in providing industrial gases & services to various industries including chemical, electronic and medical manufacturers. The main business segments of the company are Gas & Services. The revenue of the company is USD 24,839.79 Million. Number of employees is 65,000. The company has global presence in Americas, Europe, Asia-Pacific, Middle East & Africa.

In January 2018, Air Liquide entered Saudi Arabia’s healthcare market by acquiring the respiratory unit of Thimar Al Jazirah (Saudi Arabia). This strategy helped the company to expand its business in healthcare activity and enhance its customer base in the Middle East.

AIR PRODUCTS AND CHEMICALS, INC.

Air Products and Chemicals, Inc. was founded in 1940 and headquartered in Pennsylvania, U.S. The company involved in offering customers of a wide range of industries, including refining, chemical, metals, electronics, manufacturing, and food and beverage by supplying product of atmospheric and process gases, equipment and services. The main business segments of the company are Industrial Gases– Americas, Industrial Gases–EMEA, Industrial Gases– Asia, Industrial Gases–Global. The revenue of the company is USD 8,930.00 Million. Number of employees is 16,300. The company has global presence in U.S./Canada, Europe/Middle East/Africa, China, Asia (excluding China), Latin America

In November 2018, Air Products and Sonatrach declared about their industrial gases contracts in Algeria. For Air Products and Chemicals the HELIOs plant is very important as this can increase the amount of liquid helium produced in their JV plant.

To Enquire Regarding This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-gases-market

DRIVERS:

INCREASE IN THE OCCURRENCE OF CHRONIC DISEASES

According to World Health Organization, the occurrence rate of chronic diseases is rapidly growing all over the world, causing more number of deaths. The occurrence rate of chronic diseases is increasing day by day in the worldwide population. Medical oxygen is given to the patients suffering from Chronic Obstructive Pulmonary Disease (COPD), Asthma and Chronic bronchitis.

According to the WHO reports of 2001, 60.0% of the total reported deaths of 56.5 million in the world are due to the chronic diseases and the worldwide burden of disease is around 46.0%.

About 133 million Americans which is 45.0% of the total population is suffering from at least one chronic disease.

Seven out of every 10 deaths is caused due to chronic disease, in the U.S., which is more than 1.7 million deaths in America yearly
With the increase in the prevalence rate the treatment and diagnosis needs are also increasing, thus becoming a major driver for the global medical gas market.

RAPIDLY GROWING GERIATRIC POPULATION

The global population of older people continues to grow at an unmatched rate. With the growing geriatric across the world is leading to the increase of age related problems. With the increasing age the functionality of the lungs are getting weaker and the diaphragm gets weaker which leads to difficulty in opening the airway thus making the air sacs baggy and the defence mechanisms of lungs stops because of which older people becomes more susceptible to pneumonia.

According to United Nations, in 2017, 25.0% of the European population was 60 or over. It is estimated that rapid ageing would occur in other parts of the world too, so by 2050, except for Africa, all other regions of the world will nearly have a quarter or more of their populations in the geriatric age group

With the rising geriatric population, prevalence of diseases and their treatment needs are also increasing which has led to the rise become a major driver of the medical gas market

INCREASING INCIDENCE OF PRETERM CHILD BIRTHS

A pregnancy usually lasts nearly around 40weeks. If the babies are born alive before the completion of 37 weeks then it is called as Preterm birth. Babies born in less than 37 week gestation suffer with pulmonary surfactant deficiency in the lungs. Symptoms and signs of pulmonary surfactant deficiency of babies include use of accessory muscles, grunting respirations, and nasal flaring.

The proportion of preterm birth in 184 countries ranges from 5%-18%. In Africa and South Asia the percentage of preterm birth is more than 60%. The percentage of preterm birth in the lower-income countries is12.0% and the percentage of preterm birth in higher-income countries is 9.0%

With the growing incidence of preterm birth the demand for their supportive care is also increasing at a higher rate. This increasing demand has provided an opportunity for the companies to focus on the production of medical gas at a large quantity and hence it has contributed to the demand for medical gas market.

Speak to Analyst @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-medical-gases-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.